Menu Back to Introduction-to-Drug-Safety


This module is part of the DIA Drug Safety eLearning Program. The Introduction to Drug Safety module provides a foundation of knowledge required to work day-to-day in clinical safety and pharmacovigilance.  
The module provides information on the legal basis for safety reporting, including a historical perspective; basic definitions and tools; the mechanics of drug safety and pharmacovigilance; reference safety information provided by the Investigator’s Brochure and postmarketing labeling; and evaluation of seriousness, expectedness, and causality.

Featured topics

  • Drug Safety: The Basics
  • Terminology
  • A “Typical” Company Safety Unit
  • Tracking a Case from Start to Finish
  • Assessing Cases
  • Reference Safety Information: The Investigator Brochure and Postmarketing Labeling

Who should attend?

Professionals working in the area of:

  • Clinical safety & pharmacovigilance
  • Clinical research
  • Regulatory affairs
  • Medical writing
  • Marketing

Learning objectives

Upon completion of this course, participants should be able to:

  • Discuss the history, principles, and regulatory framework for clinical drug safety
  • Define terms used in day-to-day pharmacovigilance work
  • Describe a typical company drug safety unit and the path of a case from start to finish
  • Explain reference safety information provided by the Investigator Brochure and postmarketing labeling
  • Explain the assessment of seriousness, expectedness, and causality of adverse events

This module takes an average of 4 hours to complete.

Contact us